System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Mauro Bombaci is an expert in Immunology at Istituto Nazionale Genetica Molecolare (Italy). Mauro Bombaci has authored 54 publications, the most recent in 2025. SLR score: 125 (community average: 125). How the SLR is computed.

LeadR Profile

Mauro Bombaci Istituto Nazionale Genetica Molecolare Italy
125 ScienceLeadR Reputation 125

Unlock

Register Login
Network Map

Immunology

Subspecialties: Rheumatology - Infectiology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2015 - 2025
Source: PubMed

Istituto Nazionale Genetica Molecolare

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 54

Citations

Citations: 1 505 1st author: 4 Last author: 3 Unique author: 0

Main journals

Front Immunol 6
Ann Rheum Dis 3
Clin Immunol 3
Infect Immun 3
Mol Cell Proteomics 3

Best Journals

Sci Immunol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Single cell RNAseq signatures refined with combiroc enhance identification of NK cells in blood and solid tissues.
PMID 41413116 — cells, blood, killer cells, natural, natural science disciplines, tissues		Sci Rep20250
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598.
PMID 41172770 — nanoparticles, pharmaceutical preparations, brain, cholesterol, huntington disease		J Control Release20250
Corrigendum to "Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease" [Pharmacol. Res. 194 (2023) 106823].
PMID 41125486 — brain, cholesterol, pharmacology, huntington disease		Pharmacol Res20250
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors.
PMID 41080595 — seroconversion, cells, vaccines, neoplasms, drug therapy, vaccination, covid-19, immune system diseases, immunity, b-lymphocytes, chemotherapy		Front Immunol20250
Dual Activation-Induced Marker Combinations Efficiently Identify and Discern Antigen-Specific and Bystander-Activated Human CD4 T Cells.
PMID 39663678 — cells, lymphocytes, predictive value of tests, allergy and immunology, t-lymphocytes		Eur J Immunol20240

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS